1
EXHIBIT 99.1
Slide 1:
Colorado MEDtech, Inc.
March 2001 Corporate Presentation
Graphic: Photo montage of Colorado MEDtech, Inc. products
Slide 2:
Safe Harbor Statement
The statements in this presentation that are not historical facts are
forward-looking statements that represent management's beliefs and assumptions
based on currently available information. Forward-looking statements can be
identified by the use of words such as "believes," "intends," "may," "will,"
"should," "anticipated" or comparable terminology or by discussions of strategy.
Although the Company believes that the expectations reflected in such
forward-looking statements are reasonable, it cannot assure that these
expectations will prove to be correct. Such statements involve risks and
uncertainties including, but not limited to, the risk that the Company's
existing level of orders may not be indicative of the level or trend of future
orders, the risk that the Company may not successfully complete the work
encompassed by current or future orders, the risk that unforeseen technical or
production difficulties may adversely impact project timing and financial
performance, the risk that the management changes will not produce the desired
results, the risk of potential litigation, the risks associated with regulation
by the Federal Food and Drug Administration including compliance with the
Quality System Regulation, the risk that acquired companies cannot be
successfully integrated with the Company's existing operations and the risk that
a downturn in general economic conditions or customer budgets may adversely
affect research and development and capital expenditure budgets of potential
customers upon which the Company is dependent. Should one or more of these risks
materialize (or the consequences of such a development worsen), or should the
underlying assumptions prove incorrect, actual results could differ materially
from those forecasted or expected. These factors are more fully described in the
Company's documents filed from time to time with the Securities and Exchange
Commission. The Company assumes no duty to update any forward-looking
statements.
Slide 3:
OUR VISION
To be the worldwide leader in advanced medical products outsourcing - design,
development, critical components and manufacturing.
Slide 4:
Colorado MEDtech provides:
2
Complete turnkey design, engineering and manufacturing service or selected
single phase service for value-added and technology driven medical companies...
- - Product Definition/Feasibility
- - Design
- - Development
- - Machine Shop
- - Clinical Prototypes
- - FDA Submissions Support
- - Pilot Production
- - Manufacturing
- - Warranty Service and Depot Repair
Slide 5:
Who Are Our Customers?
We work in close cooperation with major medical device, pharmaceutical, biotech,
and health care companies.
Abbott Laboratories
Affymetrix
Applied Biosystems
Bausch & Lomb
Baxter
Bayer
Becton Dickinson
Boston Scientific
Carter Wallace
Dade International
Deltec
Trek Diagnostics
Dupont
Eli Lilly
GE Medical Systems
Gene Logic
Hitachi Medical Corp.
Instrumentation Labs
Johnson & Johnson
Mallinckrodt/Nellcor/Tyco
Medtronic
Ohmeda
Pharmacia
3
Physio-Control
St. Jude Medical
Siemens
SpaceLabs Medical
Stryker
Target Therapeutics
Valleylab/Tyco
Xanthon
And many more...
Slide 6:
Executive Summary
On June 23, 2000 Stephen K. Onody was appointed CEO and quickly:
- - Implemented a corporate restructuring program
- - Appointed a new management team
- - Greater focus on strengthening core businesses in designing, engineering
and manufacturing of value-added medical products to establish the platform
for future growth
- medical technology and software services
- imaging services
Slide 7:
Executive Summary
- - Assessment of non-core businesses
- - Rationalization of the overall Company to enhance long-term profitability and
growth as a quality leader in its core businesses
- - Greater focus on restoring investor goodwill:
- I am committed to tell the "Good, Bad and the Ugly"
Slide 8:
Executive Summary
- - Greater focus on key success elements:
- People and management team
- Processes
- Customer satisfaction
- Sales and profitability
4
Implementing plan to build world-class outsourcing operation
Slide 9:
Key Accomplishments FY01
People and Management Team
New management
- - Bill Wood: Senior VP Product Development and Technology
- - Greg Gould: Chief Financial Officer
- - Richard Schoen: VP Business Development
Graphic: Photos of Bill Wood, Greg Gould, and Richard Schoen
Slide 10:
Key Accomplishments FY01
People and Management Team, Continued
- - Kenneth D. Taylor, Ph.D.: VP and RELA GM
- - Frank Maguire: Chief Operations Officer
- - Chuck Philipp: VP Sales
- - Jim Vetricek: VP Quality and Regulatory Affairs
Graphic: Photos of Kenneth Taylor, Frank Maguire, Chuck Philipp and Jim Vetricek
Slide 11:
Key Accomplishments FY01
People and Management Team, Continued
Significant progress in hiring and retaining technical personnel.
Slide 12:
Key Accomplishments FY01
Processes and Infrastructure
- - Developed a plan which addresses:
- People
5
- Systems
- Facilities
- Quality
- - Emphasizing training
- - Upgrading material control systems
- - Establishing manufacturing centers
- - Consolidating facilities
We have made organizational changes in order to achieve our goal of developing a
world-class organization.
Slide 13:
Key Accomplishments FY01
Customer Satisfaction
- - Expanded existing business with current customers
- - Added 22 new customers
- - Continue to transition key projects from development to manufacturing
Slide 14:
"OneSource OutSource"(TM)
Sales and Profitability
- - Continued focus on OneSource OutSource strategy
Graphic: Drawing of funnel
"Filling the Funnel": Sales Marketing = Design & Engineering Specialized
Manufacturing = Products
- - One-stop service
- - Faster time to market
- - Innovative technical solutions
- - Integrated technical solutions
- - Integrated development and manufacturing
Results: YTD Increased Bookings
6
Slide 17:
Key Accomplishments FY01
Other Highlights
- - August 2000 - The DENVER POST lists Colorado MEDtech as one of the 100
top-Performing Public Companies
- - September 2000 - FORTUNE magazine names Colorado MEDtech to its 100 fastest
growing companies list for the second year in a row
- - October 2000 - The DENVER BUSINESS JOURNAL names Colorado MEDtech as one of
the Top 100 Colorado Companies
- - October 2000 - Deloitte & Touche gives Colorado MEDtech a Colorado Technology
Fast 50 award
- - December 2000 - Colorado MEDtech announces increased expenditures in quality
systems
- - December 2000 - Colorado MEDtech acquires assets of the ultrasound supplies
group of ATL Ultrasound. We also sign a five year product development contract
with ATL
- - February 2001 - Anthony J. Dimun joins Colorado MEDtech Board of Directors
Slide 18
U.S. Outsource Market
- - $60B Medical Device Market Growing 8-10% per year
- - $90B Electronics Mfg. Service Market Growing 25% per year
- - $3B Medical Device Outsourcing Market
Source: HIMA, Technology Forecasters, Inc. and analyst estimates. (1998 figures)
Graphic: Photo montage of products
Slide 19
A Closer Look:
CMED's Portion of the Outsourcing Market:
- - Ultra-High Tech and Value Added
- - Low-Value Built-to-Print
Graphic: Photo montage of products showing that CMED's portion of the
outsourcing market is the ultra-high tech and value-added portion
Slide 20
Core Organizational Structure
7
Colorado MEDtech, Inc.
Medical Technology and Software Services
----------------------------------------
RELA
Design
Develop
Manufacture
Distribute
|
OEM
Imaging Services
----------------
CIVCO IPS
Design Design
Develop Develop
Manufacture Manufacture
Distribute Distribute
| |
OEM OEM
|
End User
Slide 21
Corp. Headquarters and RELA, Boulder, CO
- - 500+ Total Employees
- - 130,000 total Sq. Ft.
Manufacturing Facility, Longmont, CO
Imaging & Power Systems, Longmont, CO
CIVCO, Kalona, IA
Catheter & Disposables Technology, Plymouth, MN
Graphics: Photos of Company Facilities
Graphic: Colorado MEDtech Logo
8
Slide 22
Core Business Units -- CMED RELA
- --CMED RELA
- Custom engineering, design and development for medical products which
include diagnostics, biotechnology, therapeutics and software
- Objectives for FY2001
- Continue expansion strategy: 16 new customers and 9 new contracts as well
as 7 expansion contracts added through Q2
- Introduce CMED's web-enabled medical and diagnostic device platform in
Q1 - Completed
- Introduce CMED's "thin-instrument" platform in Q2
Slide 23
Therapeutic Devices
- --CMED RELA
- - Cardiology, surgery, defibrillation
- - Electrophysiology
- - Drug delivery, infusion devices
- - Patient monitors
- - Respiratory care products
- - Urology
- - Neurological devices
Slide 24
Diagnostics & Biotechnology
- --CMED RELA
- - Handheld to high throughput systems
- - Optics, fluidics, robotics, temperature control
- - Real-time software
- - DNA-based research systems
- - DNA chip technology and systems
- - Laboratory analyzers
Slide 25
Core Business Units -- Imaging & Power Systems
IPS
- - Outsourcing services and products for medical imaging:
- A broad line of advanced power platforms
- A world class power and MRI engineering and software team
9
- Industry recognized imaging system technical resources and manufacturing
capabilities
- - Objectives for FY2001
- Product Pipeline
- Fully commercialize Computed Tomography ("CT") power source
- Development of MRI -- Solid state power source
- - Increase sales by capitalizing on strong relationships with existing customer
base
- - Expansion strategy: new products with existing customers; added 1 new customer
and 6 new contracts through Q2
Slide 26
IPS
- - MRI development services
- - MRI amplifiers
- - High-voltage CT x-ray generators
- - Embedded digital control
- - Advanced application software
- - Embedded system software
Slide 27
Core Business Units -- CIVCO
CIVCO
- - Develops and manufactures specialized medical products for ultrasound imaging
and minimally invasive surgical equipment
- - Objectives for FY2001
- Focus on corporate accounts for single source solutions in product
development and distribution
- Expansion of market opportunity via exclusive development arrangements with
manufacturers
Slide 28
CIVCO
- - Needle guidance systems
- - Transducer covers
- - Ultrasound supplies
- - Brachytherapy products
- - Surgical device, sterile covers
- - Minimally invasive accessories
10
Slide 29
Conclusion: "Achieving our vision"
- - Focus on core operations to improve profitability and operating cash flow
while providing a more complete solution for our clients
- - Re-dedication to strong customer service and customer satisfaction, leading to
revenue growth acceleration
Slide 30
Conclusion: "Achieving our vision"
- - Performance-based stock and bonus compensation will continue to improve
employee satisfaction and align their interests with shareholders
- - Once operating turn-around is substantially completed, strategic
acquisitions and alliances will create synergies and further power growth
Slide 31
Key Accomplishments FY01
Financial Information for the Six Months Ended December 31, 2000
- - Revenue $35.8 million
- - $2k net income prior to one-time charges
- - Net cash flow provided by operating activities of $1.9 million
- - Bookings increased to $40-50 million -- keeps us on track toward meeting goals
announced on August 22, 2000
- - Strong balance sheet
- $17.3 million up from $16.8 million
- A/R decreased $1.4 million
- Debt ~ $100K
Slide 32
Colorado MEDtech, Inc.
- - One stop service
- - Faster time to market
- - Innovative technical solutions
- - Full service product commercialization
- - ISO 9001